Darmiyan

Darmiyan is a pioneering brain technology (deep-tech) company based in San Francisco, California, focused on developing innovative and rapidly scalable products for brain health screening and monitoring. The companys mission is to enhance brain health, equipping physicians with tools for precise, personalized patient care, thereby optimizing health outcomes. Darmiyans first product, BrainSee, is FDA-approved and available to physicians to aid in prognosis of patients diagnosed with amnestic mild cognitive impairment (aMCI)

Mri analysis,early detection,patient selection,therapeutic evaluation,modeling,machine learning,microscopy,ai,mild cognitive impairment,alzheimer's,diagnostics,prognostics,monitoring,cloud,neuroscience,radiology,data science,brain health,aging,longevity,and brain

Darmiyan operates in the Medical and diagnostic laboratories industry.

Darmiyan's revenue is 11m - 100m

Darmiyan has 11 - 50 employees.